Skip to main content

Table 1 Studies of retinal blood flow changes in cerebral pathology

From: Retinal blood flow in critical illness and systemic disease: a review

Cerebral studies

Species

Imaging modality

Pathology

Metrics measured

Findings

Frost et al. [94]

Human

Retinal photograph—Merge EyeScanner Camera

Stroke

Retinal vessels widths

Positive correlation between width of arterioles/venules and carotid disease in stroke patients

Kwapong et al. [95]

Human

OCTA—RTVue XR Avanti SD-OCT, Optovue

PD

Retinal vessel density of SRCP and DRCP

Macula and RNFL thickness

Decreased retinal microvascular density, thinner macula, macular GCIP and inferior RNFL in PD

Querques et al. [97]

Human

DVA—Imedos Systems UG

OCTA—Cirrus 5000 with Angioplex, Carl Zeiss Meditech

OCT—SPECTRALIS HRA + OCT device, Heidelberg

MCI and AD

Retina artery and venous changes

Perfusion density

GCL thickness

DVA found arterial dilation decreased in the AD group compared with MCI and control groups and decreased vessel reaction in AD and MCI groups compared with control

No differences in OCTA

GCL thickness reduced in central and temporal sectors of AD patients compared with controls

Kwa [105]

Human

Retinal photograph—Optimed, Inc

MRI—1.5 T Magnetom 63 SP/4000, Siemens AG

Cerebral SVD

Retinal arterial narrowing, crossings, sclerosis, tortuosity

Presence of WML or lacunar infarcts

92% of patients with cerebral SVD had at least one retinal vascular abnormality

Retinal arterial abnormalities correlated with MRI signs of cerebral SVD

Ong et al. [127]

Human

Retinal fundus photographs

Ischaemic stroke

Retinal vasculature pattern/geometry

Ischaemic stroke patients had lower fractal dimensions, greater tortuosity and narrower arteriolar calibres compared to healthy controls

Lee et al. [128]

Human

OCTA—Cirrus HD-OCT

Carotid Stenosis

Retinal vessel density of DVP

Vessel density of the DVP increased in both eyes, 1 month following treatment

Jiang et al. [102]

Human

Retinal functional imager—Optical Imaging Ltd., Israel

OCT—Cirrus, Carl Zeiss Meditech, CA

MCI and AD

Retinal blood flow rate/velocity

GCIPL thickness

Macular blood flow rate was significantly lower in AD patients than MCI and controls, and also significantly lower in MCI patients than controls. Blood flow velocity of arterioles was significantly lower in MCI than controls

GCIPL thickness was significantly reduced in AD and MCI patients than controls

Bulut et al. [103]

Human

OCTA—RTVue XR100-2, Optovue, CA

AD

Retinal vascular density

FAZ area. Choroidal thickness

AD patients had significantly lower vascular density than control group

FAZ area was significantly enlarged in AD patients compared with controls

Choroidal thickness was significantly lower in AD patients than controls

Zhang et al. [104]

Human

RTVue-XR OCT Avanti System—Optovue Inc, CA

Early AD and amnestic MCI

Retinal vessel/vessel length density

Adjusted flow index

FAZ area

RNFL thickness

Patients showed a significant decrease in the parafoveal SRCP vessel density and adjusted flow index compared with controls, but not in vessel length density

No difference in FAZ area between groups

No significant difference in any measures in the superficial vascular complex

Lahme et al. [129]

Human

OCTA—RTVue XR Avanti with AngioVue

AD

Retinal and optic nerve head flow density

Flow density of the macula was significantly lower in AD patients than controls, found to be associated with vascular cerebral lesions in AD

Abraham et al. [130]

Human

OCTA (manufacturer not specified)

At-risk MCI

Retinal vessel density

No significant association of retinal vessel density with cognitive function or risk of MCI

Wang et al. [131]

Human

Retinal functional imaging—Optical Imaging Ltd, Israel

MS

Retinal blood flow velocity

Reduced blood flow in MS patients with and without optic neuritis compared with healthy controls

Yilmaz et al. [132]

Human

OCTA—Nidek’s RS-3000

MS

FAZ area

Retinal vessel density

No difference in FAZ or perimeter, but lower macular vessel density in MS patients than healthy controls and in MS patients with optic neuritis compared to MS patients without optic neuritis

Lanzillo Cennamo, & Criscuolo [133]

Human

SD-OCT—RTVue-100 OCT, Optovue Inc

OCTA—Optovue Angiovue System, Optovue Inc

MS with a history of optic neuritis

Retinal vessel density

RNFL and GCL thickness

RNFL and GCL thickness and vessel density were lower in the MS group (with and without optic neuritis) than the control group

Beare and Harding [134]

Human

FFA—Topcon 50-EX, Topcon

Cerebral malaria

Retinal blood flow

Tissue perfusion

BRB integrity

82% of patients with cerebral malaria had perfusion abnormalities, including capillary nonperfusion, blocked retinal vessels, retinal ischaemia, intravascular filling defects and fluorescein leakage

Dallorto et al. [135]

Human

OCT and OCTA—RTVue XR Avanti

Pituitary adenoma with optic neuropathy

RNFL and ganglion cell complex thickness

Vessel density

Vessel density, RNFL thickness and ganglion cell complex thickness were all decreased in pituitary adenoma patients with optic neuropathy compared to healthy eyes

Suzuki et al. [136]

Human

OCTA—DRI OCT Triton Plus

Chiasmal compression band atrophy

Vessel density

RNFL

Those with band atrophy showed smaller average vessel density than controls, which had a strong correlation with RNFL thinning

Lee et al. [137]

Human

OCTA—DRI OCT Triton Plus

Pituitary tumour chiasmal compression

Vessel density

RNFL and GCL thickness

Before tumour removal, vessel densities, RNFL and GCL thickness were all reduced in eyes with chiasmal compression compared with healthy controls

  1. Summary of studies investigating retinal blood flow and microvascular changes in cerebral pathology
  2. OCTA, optical coherence tomography angiography; OCT, optical coherence tomography; SD-OCT, spectral-domain OCT; PD, Parkinson’s disease; SRCP, superficial retinal capillary plexus; DRCP, deep retinal capillary plexus; DVP, deep vascular plexus; RNFL, retinal nerve fibre layer; GCIPL, ganglion cell layer and inner plexiform layer; DVA, dynamic vessel analyser; MCI, mild cognitive impairment; AD, Alzheimer’s disease; GCL, ganglion cell layer; MRI, magnetic resonance imaging; SVD, small-vessel disease; WML, white matter lesions; FFA, fundus fluorescein angiography; BRB, blood–retina barrier; MS, multiple sclerosis